Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar 4:2022:7862709.
doi: 10.1155/2022/7862709. eCollection 2022.

Associations between AGT M235T Polymorphism and Cancer: An Updated Meta-Analysis

Affiliations
Review

Associations between AGT M235T Polymorphism and Cancer: An Updated Meta-Analysis

Junyan Kou et al. J Renin Angiotensin Aldosterone Syst. .

Abstract

We assessed the relationship between AGT gene M235T polymorphism and the susceptibility to cancer by performing an updated meta-analysis. This study retrospectively searched related articles in the electronic databases. Afterwards, we determined combined odds ratios (ORs) and related 95% confidence intervals (CIs) by the fixed- or random-effects model. The present meta-analysis enrolled altogether 9 articles. On the whole, the relationship between AGT M235T polymorphism and the cancer risk was not significant among the entire population (TT vs. MM: OR = 1.28, 95%CI = 0.80 - 2.04; TM vs. MM: OR = 0.90, 95%CI = 0.53 - 1.52; recessive model: OR = 1.13, 95%CI = 0.83 - 1.52; dominant model: OR = 0.93, 95%CI = 0.55 - 1.57). Subgroup analysis by ethnicity, cancer type, and study quality for the relationship between the AGT M235T polymorphism and cancer risk showed no significant association. According to findings in the present meta-analysis, AGT M235T polymorphism may not be related to cancer susceptibility.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Figures

Figure 1
Figure 1
The flow diagram of included/excluded studies.
Figure 2
Figure 2
Forest plot for meta-analysis of the association between the M235T polymorphism and cancer risk with TT vs. MM.
Figure 3
Figure 3
Sensitivity analysis of the association between the M235T polymorphism and cancer risk.
Figure 4
Figure 4
Begg's funnel plot analysis to detect potential publication bias for M235T polymorphism.

Similar articles

Cited by

References

    1. Mandal R. K., Akhter N., Haque S., Panda A. K., Mittal R. D., Alqumber M. A. A. No correlation between TIMP2 -418 G>C polymorphism and increased risk of cancer: evidence from a meta-analysis. PLoS One . 2014;9(8, article e88184) doi: 10.1371/journal.pone.0088184. - DOI - PMC - PubMed
    1. Mohammed A. A., Naseem A., Shafiul H. Evaluating the association between p 53 codon 72 Arg>pro polymorphism and risk of ovary cancer: a meta-analysis. PLoS One . 2014;9(4, article e94874) doi: 10.1371/journal.pone.0094874. - DOI - PMC - PubMed
    1. Jing J., Juan R., Dongmei Y. Association between the XRCC6 polymorphisms and cancer Risks. Medicine (Baltimore) . 2015;94(1, article e283) doi: 10.1097/MD.0000000000000283. - DOI - PMC - PubMed
    1. Suganuma T., Ino K., Shibata K., et al. Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination. Clinical Cancer Research . 2005;11(7):2686–2694. doi: 10.1158/1078-0432.ccr-04-1946. - DOI - PubMed
    1. Celerier J., Cruz A., Lamande N. Angiotensinogen and its cleaved derivatives inhibit angiogenesis. Hypertension . 2002;39(2):224–228. doi: 10.1161/hy0202.103441. - DOI - PubMed